Page last updated: 2024-08-24

isoimperatorin and angelicin

isoimperatorin has been researched along with angelicin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marumoto, S; Miyazawa, M1
Baek, SC; Cho, ML; Kang, MG; Kim, H; Lee, H; Lee, JP; Oh, SR; Park, CM; Park, D; Park, JE; Ryu, HW1
Bai, H; Jiao, Y; Li, J; Li, W; Ma, H; Ma, Q; Meng, X; Zhang, X1
Acharya, R; Bose, P; Chacko, S; Lapenna, A; Pattanayak, SP1

Other Studies

4 other study(ies) available for isoimperatorin and angelicin

ArticleYear
Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
    Bioorganic & medicinal chemistry, 2012, Jan-15, Volume: 20, Issue:2

    Topics: 5-Methoxypsoralen; Amyloid Precursor Protein Secretases; Coumarins; Furocoumarins; Kinetics; Methoxsalen; Protease Inhibitors; Structure-Activity Relationship

2012
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
    Bioorganic & medicinal chemistry letters, 2019, 03-15, Volume: 29, Issue:6

    Topics: Acetylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Coumarins; Enzyme Assays; Humans; Kinetics; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Structure-Activity Relationship

2019
[Simultaneous determination of eight furocoumarines in cosmetics by high performance liquid chromatography and verification by liquid chromatography-tandem mass spectrometry].
    Se pu = Chinese journal of chromatography, 2013, Volume: 31, Issue:5

    Topics: 5-Methoxypsoralen; Chromatography, High Pressure Liquid; Cosmetics; Ficusin; Furocoumarins; Methoxsalen; Tandem Mass Spectrometry; Trioxsalen

2013
Structure Based Multitargeted Molecular Docking Analysis of Selected Furanocoumarins against Breast Cancer.
    Scientific reports, 2019, 10-31, Volume: 9, Issue:1

    Topics: Binding Sites; Breast Neoplasms; Catalytic Domain; Drug Design; ErbB Receptors; Estrogen Receptor alpha; Female; Furocoumarins; Humans; Ligands; MCF-7 Cells; Molecular Docking Simulation; TOR Serine-Threonine Kinases

2019